DANA BROWN: Open Payments
NPI 1073907192 · CONNELLY SPRINGS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 47 payments from 18 companies in 2025. Trend: 2023 $15 · 2024 $354 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $171 |
| Neurocrine BioSciences, Inc. | 4 | $84 |
| Teva Pharmaceuticals USA, Inc. | 4 | $82 |
| Gilead Sciences, Inc. | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Lundbeck LLC | 2 | $51 |
| Verona Pharma, Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $37 |
| Indivior Inc. | 1 | $36 |
Products named: VRAYLAR, INGREZZA, AUSTEDO XR, REXULTI, FARXIGA, Ohtuvayre, Auvelity, MOUNJARO.
Industry payments across NC — which companies pay providers there.
